tirzepatide a glp1 Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of | Cardiovascular Diabetology Republican Administration Maintains Exclusivity Stance

This injectable medication is FDA-approved for treating type 2 diabetes and is also being studied for its efficacy in weight loss in individuals with obesity or those who are overweight with weight-related comorbidities

The drugs mimic a hormone in the body called GLP-1 that triggers an increase in the production of insulin, slows the rate at which food is digested in the stomach, and reduces appetite

But one delivers a gentle starting dose while the other delivers the absolute ceiling of the medication

Does Body Pharm ship retatrutide to all UK addresses

What comes next

A healthcare professional will start the dose of retatrutide at a lower level with the aim of allowing your body time to adjust